Kivu Bioscience
About:
Kivu Bioscience is a biotechnology company that focuses on developing next-generation antibody-drug conjugates to target cancer.
Website: https://kivubioscience.com
Top Investors: Novo Holdings, M Ventures, BOM, BioGeneration Ventures, HealthCap
Description:
Kivu Bioscience is a biotech company developing next-generation antibody-drug conjugates to deliver best-in-class therapeutics and focused on rapidly advancing next generation transformative assets.
Total Funding Amount:
$92M
Headquarters Location:
San Francisco, California, United States
Founded Date:
2024-01-01
Founders:
Number of Employees:
1-10
Last Funding Date:
2024-10-28
IPO Status:
Private
Industries:
© 2025 bioDAO.ai